Skip to content

Construction and Application of a Food Reintroduction Protocol after Remission Induced by Exclusive Enteral Nutrition in Children with Crohn's Disease

Construction and Application of a Food Reintroduction Protocol after Remission Induced by Exclusive Enteral Nutrition in Children with Crohn's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000618
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Interventions

Control Group:In the control group of this study, patients after achieving EEN-induced remission received conventional dietary guidance: gradually introducing low-fat, low-residue foods within 2-4 wee
intervention group:The intervention group received the food reintroduction protocol for pediatric CD patients after EEN-induced remission, in addition to the conventional dietary intervention provided

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medicine University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) Confirmed diagnosis of CD according to the diagnostic criteria in the 2019 Chinese Medical Association "Expert Consensus on Diagnosis and Treatment of Pediatric Inflammatory Bowel Disease"; 2) Age < 18 years; 3) Received exclusive enteral nutrition (EEN) treatment and achieved EEN-induced remission without prior food reintroduction; 4) Good compliance and ability to maintain communication after discharge; 5) Provided informed consent and willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Critically ill patients requiring surgical intervention; 2) Patients with severe complications involving the heart, liver, kidneys, or other organs, or with serious underlying comorbidities.

Design outcomes

Primary

MeasureTime frame
PCDAI;

Secondary

MeasureTime frame
Inflammatory Biomarkers;Nutritional Assessment;

Countries

CHINA

Contacts

Public ContactZHOU MI

The First Affiliated Hospital of Zhejiang University of Chinese Medicine (Zhejiang Provincial Hospital of Traditional Chinese Medicine)

18858260443@139.com+86 188 5826 0443

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026